Jonathan C. Roberts - 27 Jan 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP & Chief Operating Officer
Signature: Jonathan C. Roberts
Issuer symbol: CVS
Transactions as of: 27 Jan 2022
Net transactions value: -$358,846
Form type: 4
Filing time: 28 Jan 2022, 15:58:03 UTC
Previous filing: 05 Nov 2021
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Options Exercise	$7,002,969	+68,482	+64%	$102.26	175,597	27 Jan 2022	Direct
transaction	CVS	Common Stock	Sale	$7,361,815	-68,482	-39%	$107.50	107,115	27 Jan 2022	Direct	F1
holding	CVS	Common Stock						34,707	27 Jan 2022	By GRAT
holding	CVS	Common Stock (restricted)						12,812	27 Jan 2022	Direct
holding	CVS	ESOP Common Stock						6,045	27 Jan 2022	By ESOP

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Options Exercise	$0	-68,482	-100%	$0.000000^*	0	27 Jan 2022	Common Stock	68,482	$102.26	Direct	F2
holding	CVS	Phantom Stock Credits						1,423	27 Jan 2022	Common Stock	1,423	$1.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales were effected pursuant to a Rule 10b5-1 plan.
F2	Option became exercisable in four equal annual installments, commencing 4/1/2016.
F3	Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.